Biogen, Inc.

Biogen, Inc. is a leading global biotechnology company dedicated to discovering, developing, and delivering innovative therapies for neurological diseases. Founded in 1978, Biogen has been at the forefront of scientific advancements, focusing on areas such as multiple sclerosis, spinal muscular atrophy, and Alzheimer’s disease.

The company operates with a strong commitment to improving patient outcomes through cutting-edge research and development. With a robust pipeline of therapies, Biogen aims to address unmet medical needs and enhance the quality of life for patients worldwide.

Core Activities

• Research and Development: Biogen invests heavily in R&D to discover new treatments and improve existing therapies.
• Manufacturing: The company has state-of-the-art manufacturing facilities that ensure the highest quality standards for its products.
• Patient Support: Biogen provides comprehensive support services to help patients access their medications and manage their conditions.

Biogen’s vision is to lead the way in neuroscience by harnessing the power of science and technology. The company collaborates with academic institutions, healthcare professionals, and other stakeholders to drive innovation and bring new therapies to market.

With a global presence, Biogen is committed to sustainability and corporate responsibility, striving to make a positive impact on communities and the environment. The company’s dedication to ethical practices and transparency is reflected in its operations and interactions with stakeholders.

As Biogen continues to grow, it remains focused on its mission to transform the lives of people living with serious neurological diseases, ensuring that every patient has access to the best possible care.